Davoud Mohtat, MD| Pediatric Nephrology | MedStar Health

Davoud Mohtat, MD
Provider accepts MedStar Select insurance

Specialties: Pediatric Nephrology

Languages: Persian Farsi, Farsi, Turkish, English

(877) 680-5502

Clinical areas of focus

  • Chronic Kidney Disease (CKD)
  • Glomerulonephritis
  • Hematuria
  • Hypertension
  • Kidney Stone
  • Nephrotic Syndrome
  • Proteinuria
Show More

Conditions and procedures

Conditions I treat

  • Chronic Kidney Disease (CKD)
  • Diabetic Nephropathy
  • Focal Segmental Glomerulosclerosis
  • Glomerulonephritis
  • Hematuria
  • Hypertension
  • Kidney Stone
  • Lupus Nephritis
  • Nephrotic Syndrome
  • Proteinuria
Show All Show Less

Practice locations

Distance from Change LocationEnter your Location

4200 Wisconsin Avenue Northwest
Suite 400
Washington, DC, 20016

202-243-3400

Fax 202-243-3434

Get Directions

miles away

Fax 202-243-3434

Insurance

MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • UnitedHealthcare and AARP Medicare Complete Plans/ UHC Group Medicare Advantage Plans HMO, POS, PPO
    • Blue Choice Advantage & Healthy Blue (HMO, POS)
    • United Healthcare Options (PPO) (includes Empire PPO, GEHA, Compass Rose)
    • Kaiser Permanente Medicare Advantage Signature and Select (aka Senior Advantage)
    • CFBCBS Federal Employee Program (Std/Basic PPO/Blue Focus)
    • Private Health Care Systems (PHCS) (PPO)
    • Kaiser Permanente Flexible Choice POS
    • UHC Community Plan of MD
    • Kaiser Virginia Premier
    • Kaiser PermanenteSelect-Added Choice
    • Kaiser Permanente Signature-Added Choice
    • Kaiser Permanente Medicare Plus (Medicare Supplemental Plan)
    • UnitedHealthcare Medicare Adv/Special Needs Plans
    • Kaiser MD Medicaid MCO
    • Kaiser Permanente Signature
    • Kaiser Permanente Select
    • Medicare Fee for Service
    • CFBCBS EPO
    • PPO and PPO Plus
    • Aetna Traditional Choice (PPO)
    • Choice POS & Choice POS II
    • Select HMO/HealthFund/Health Network
    • Aetna Managed Choice (POS)
    • Network OA
    • Opoen HMO Option
    • Aetna Innovations: HMO & EPO Plus
    • POS OA & OA Plus
    • United Healthcare Choice
    • Open EPO Plus
    • Choice Fund PPO
    • Open HMO
    • HealthyBlue PPO
    • Aetna Elect Choice/ Open Access (POS)
    • Innovation Health: POS Plus
    • Innovation Health: Open Network Only Plus
    • Innovation Health: PPO
    • CIGNA EPO
    • Innovation Health: POS
    • Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
    • Open POS II
    • Aetna HMO
    • CFBCBS Blue Choice Opt Out Open Access
    • Innovation Health: Indemnity
    • Innovation Health: Open POS Plus
    • CFBSBC Blue Preferred PPO
    • Aetna Open Choice (PPO)
    • CIGNA HMO Open Access (OA)
    • Aetna Managed Choice Open Access (POS)
    • BlueChoice Open Access
    • Coventry of Delaware HMO/PPO
    • MedStar Family Choice - Maryland Health Choice
    • First Health PPO
    • M.D. IPA (HMO)
    • CFBCBS BlueChoice HMO
    • CFBCBS Maryland Point of Service Plan (MPOS)
    • Aetna Elect Choice/ EPO (Aetna Health Fund) Innovation Health: Network Only Plus
    • CIGNA HMO & Network (HMO)
    • Great-West Healthcare POS/CIGNA
    • Tricare for Life (Medicare Supplemental Plan)
    • United Student Resources
    • CIGNA Indemnity
    • United Healthcare Choice Plus
    • Aetna Worker's Compensation Network
    • Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • Coventry Health Care National Network PPO
    • Coventry Health Care of Virginia
    • M.D. IPA Preferred (POS)
    • CFBCBS (NCA) Indemnity
    • Aetna Student Health Insurance
    • CFBCBS Blue Choice Opt Out Plus Open Access (POS)
    • Aetna Quality Point of Service (POS)
    • CFBCBS Maryland Indemnity or PPO
    • United Healthcare Select HMO - EPO/NPP
    • FIRST HEALTH
    • United Healthcare Select Plus (POS)
    • CIGNA POS/Network POS
    • Mamsi Life & Health (Indem./PPO)
    • Tricare Prime
    • Aetna Medicare Advantage HMO & PPO Plans
    • MedStar Select (MedStar Associates' Plan)

Education

Board Certification: American Board of Pediatrics, Pediatrics

Fellowship: Albert Einstein College of Medicine-Yeshiva University (2010)

Residency: SUNY Downstate (2007)

Medical School: Uludag Universitesi (1998)

News and publications

 



Transcriptome analysis of human diabetic kidney disease.



Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K.Diabetes. 2011 Sep;60(9):2354-69. doi: 10.2337/db10-1181. Epub 2011 Jul 13.PMID: 21752957 Free PMC article.



Fine tuning gene expression: the epigenome.



Mohtat D, Susztak K.Semin Nephrol. 2010 Sep;30(5):468-76. doi: 10.1016/j.semnephrol.2010.07.004.PMID: 21044758 Free PMC article. Review.



Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.



Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, Fazzari M, Verma A, Zheng D, Greally JM, Susztak K.Genome Biol. 2013;14(10):R108. doi: 10.1186/gb-2013-14-10-r108.PMID: 24098934 Free PMC article.



Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.



Hu CY, Mohtat D, Yu Y, Ko YA, Shenoy N, Bhattacharya S, Izquierdo MC, Park AS, Giricz O, Vallumsetla N, Gundabolu K, Ware K, Bhagat TD, Suzuki M, Pullman J, Liu XS, Greally JM, Susztak K, Verma A.Clin Cancer Res. 2014 Aug 15;20(16):4349-60. doi: 10.1158/1078-0432.CCR-14-0494. Epub 2014 Jun 10.PMID: 24916699 Free PMC article.



Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.



Mohtat D, Thomas R, Du Z, Boakye Y, Moulton T, Driscoll C, Woroniecki R.Pediatr Nephrol. 2011 Feb;26(2):275-80. doi: 10.1007/s00467-010-1677-9. Epub 2010 Nov 25.PMID: 21107986



Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.



Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ; TEMPO Open-label Study Group.Mov Disord. 2009 Mar 15;24(4):564-73. doi: 10.1002/mds.22402.PMID: 19086083 Clinical Trial.